The in vitro effects of new non-steroidal antiinflammatory compounds on antioxidant system of human erythrocytes

Experimental and Toxicologic Pathology

Volumn 51, Issue 4-5, 1999, Pages 397-402

  Orhan, H ^a   Dogruer D S ^b   Cakir B ^b   Sahin G ^a   Şahin, M Fethi ^b  

^a HACETTEPE UNIVERSITY   (Turkey)

^b GAZI UNIVERSITY   (Turkey)

Author keywords

Antianalgesics; Antiinflammatory compounds; Antioxidant system; Erythrocytes; Human

Indexed keywords

BENZOTHIAZOLE DERIVATIVE; BENZOXAZOLE DERIVATIVE; DICLOFENAC; FREE RADICAL; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; SCAVENGER; XENOBIOTIC AGENT;

ANTINOCICEPTION; ANTIOXIDANT ACTIVITY; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME ACTIVITY; ERYTHROCYTE; HUMAN; HUMAN CELL; INFLAMMATION; OXIDATIVE STRESS;

LETHRINIDAE;

EID: 0344690055     PISSN: 09402993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0940-2993(99)80028-1     Document Type: Conference Paper

References (26)

1. AEBI H: Catalase in vitro. Meth Enzymol 1984; 105: 121-126.
2. ARUOMA OI, HALLIWELL B: The iron binding and hydroxyl radical scavenging action of NSAIDs. Xenobiotica 1988; 18: 459-470.
3. ARUOMA OI, et al: Apparent inactivation of alpha 1-antiproteinase by sulphur-containing radicals derived from penicillamine. Biochem Pharmacol 1989; 38: 4353-4357.
4. DOǦRUER DS, ÜNLÜ S, YEŞILADA E, ŞAHIN MF: N-(2-Pyridyl)-2-[2(3H)-Benzazolone-3-yl]acetamides: Synthesis and antinociceptive and anti-inflammatory activity, IL Farmaco 1997; 52 (12): 745-750.
5. DYKENS JA, SULLIVAN SG, STERN A: The red cell as a model for drug-induced oxidant stress In: C. Rice Evans (ed). Free Radicals Oxidant Stress and Drug Action. London. Richelieu Press. 1987, 331-343.
6. EVANS PJ, et al.: Oxidative damage to lipids and alpha(1) antiproteinase by phenylbutazone in the presence of heme-proteins protection by ascorbic acid. Biochem Pharmacol 1992; 44 (5): 981-984.
7. FURST DE: Are there differences among NSAIDs? Arthiritis and Rheumatism 1994; 37 (1): 1-9.
8. HABIG WB, PABST MJ, JAKOBY WB: Glutathione S-transferase: The first enzymatic step in mercapturic acid formation. J Biol Chem 1974; 249: 7130-7139.
9. HALLIWELL B, GUTTERIDGE JMC: The importance of free radicals and catalytic metal ions in human disease. Molecular Aspects of Medicine 1985; 8: 89-193.
10. HALLIWELL B, GUTTERIDGE JMC: Formation of thiobarbituric-acid reactive substance from deoxyribose in the presence of iron salts: the role of superoxide and hydroxyl radicals. FEBS Letter 1981; 128: 347-352.
11. HILLER KO, HODD PL, WILSON RL: Anti-inflammatory drugs: protection of a bacterial virus as an in vitro biological measure of free radical activity. 1983; 47 (3): 293-305.
12. MAFFEI FACINO R, CARINI M, SAIBENE L: Scavenging of free radicals by tenoxicam: A participating mechanism in the antirheumatic/antiinflammatory efficacy of the drug. Arch Pharm Med Chem 1996; 329: 457-463.
13. MARKLUND S, MARKLUND G: Involvement of superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. European Journal of Biochemistry 1974; 47: 469-474.
14. MILLER GL: Protein determination for large numbers of samples. Anal Chem 1959; 31: 964.
15. MITCHELL JA, AKARSEREENONT P, THIEMERMANN C, et al.: Selctivity of NSAIDs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci USA 1994; 90: 11693-11697.
16. MULLER-PEDDINGHAUS R, WURL M: The amplified chemiluminascence test to characterize antirheumatic drugs as oxygen radical scavengers. Biochem Pharmacol 1987; 36: 1125-1132.
17. NELSON DA, MORRIS MW: In Clinical Diagnosis and Management by Laboratory Methods. H. J. BERNARD, ed., Philadelphia: WB Saunders Company, 1991: 556-557.
18. PEKOE G, et al.: Comparison of the effects of antioxidant non-steroidal anti-inflammatory drugs against myeloperoxidase and hypochlorous acid luminol-enchanced chemiluminascence. Agents Actions 1982; 12: 232-238.
19. PLEBAN PA, MUNYANI A, BEACHUM J: Determination of selenium concentration and glutathione peroxidase activity in plasma and erythrocytes. Clin Chem 1982; 28: 311-316.
20. th ed. London. The Pharmaceutical Press. 1989.
21. RICE-EVANS C: In: Free radicals, oxidant stress and drug action. The Richelieu press, 1987, London.
22. SHEN H et al.: Identification of cystine residues involved in disulfide formation in the inactivation of glutathione s-transferase P form by hydrogen peroxide. Arch Biochem Biophys 1993; 300: 137-141.
23. VELO GP, MILANINO R: Nongastrointestinal Adverse Reactions to NSAID. J Rheumatol 1990 (Suppl 20); 17: 42-45.
24. WASIL M, et al.: Biological significant scavenging of myeloperoxidase derived oxidant hypochloric acid by some anti-inflammatory drugs. Biochem Pharmacol 1987; 36 (22): 3847-3850.
25. WHITEHOUSE MW: Some biochemical and pharmacological properties of anti-inflammatory drugs. Progress in Drug Research 1965; 8: 321-429.
26. ZUURBIER KWM, et al.: Interaction of myeloperoxidase with diclofenac. Biochem Pharmacol 1990; 40 (8): 1801-1808.